{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:06:56Z","timestamp":1759334816350,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.jaad.2006.08.053","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T12:22:44Z","timestamp":1196079764000},"page":"S92-S96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S","title":["Primary cutaneous anaplastic large cell lymphoma with fatal leukemic outcome in association with CLA and CCR4-negative conversion"],"prefix":"10.1016","volume":"57","author":[{"given":"Yoshiki","family":"Tokura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Shimauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.08.053_bib1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0889-8588(03)00117-5","article-title":"Primary cutaneous CD30-positive lymphoproliferative disorders","volume":"17","author":"Willemze","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2006.08.053_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","article-title":"Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype","volume":"109","author":"Kummer","year":"1997","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.08.053_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/1523-1747.ep12330845","article-title":"Th2 cytokine mRNA\u00a0expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant\u00a0interferon-gamma","volume":"107","author":"Yagi","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.08.053_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1600-0560.2002.290507.x","article-title":"Fascin expression in CD30-positive cutaneous lymphoproliferative disorders","volume":"29","author":"Kempf","year":"2002","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2006.08.053_bib5","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V86.5.1954.bloodjournal8651954","article-title":"Anaplastic large cell\u00a0lymphomas expressing the novel chimeric protein p80NPM\/ALK: a distinct clinicopathologic entity","volume":"86","author":"Shiota","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.08.053_bib6","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":"The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin","volume":"87","author":"DeCoteau","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.08.053_bib7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V88.5.1765.1765","article-title":"Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease","volume":"88","author":"Wood","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.08.053_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1600-0560.1997.tb01090.x","article-title":"The t(2;5)-associated p80 NPM\/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders","volume":"24","author":"Su","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2006.08.053_bib9","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.08.053_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaad.2003.12.028","article-title":"Management of\u00a0multifocal primary cutaneous CD30 anaplastic large cell lymphoma","volume":"51","author":"Shehan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.053_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archderm.1988.01670030071025","article-title":"Ki-1+ cutaneous lymphoma. Gene rearrangement analysis of tumor cells in tissue and short-term culture of a patient","volume":"124","author":"Sugimoto","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.053_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0190-9622(09)80091-1","article-title":"Primary cutaneous CD30-positive large-cell lymphoma: a case with fatal outcome","volume":"31","author":"Curco","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.053_bib13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2006.08.053_bib14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.08.053_bib15","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1158\/1078-0432.CCR-04-0491","article-title":"Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells","volume":"11","author":"Shimauchi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2006.08.053_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206023516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206023516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:07:07Z","timestamp":1759270027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206023516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0190962206023516"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.08.053","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cutaneous anaplastic large cell lymphoma with fatal leukemic outcome in association with CLA and CCR4-negative conversion","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}